$STME
Stimcell Energetics Inc.

2025 Q1 Form 10-Q Financial Statement

#000139390525000019 Filed on January 14, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $130.7K
YoY Change 207.08%
Operating Profit
YoY Change
Interest Expense $8.810K
YoY Change -51.01%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$139.5K
YoY Change 130.41%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 19.82M shares 297.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2025 Q1 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $33.82K
Short-Term Investments
Other Short-Term Assets $4.525K
YoY Change 1640.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $38.35K
YoY Change 67.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $316.3K
YoY Change -51.2%
Accrued Expenses $12.34K
YoY Change 48.12%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $1.021M
YoY Change -59.93%
SHAREHOLDERS EQUITY
Retained Earnings -$10.50M
YoY Change 2.05%
Common Stock $19.82K
YoY Change -68.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $38.35K
YoY Change 67.57%

Cashflow Statement

Concept 2025 Q1 2024 Q4
OPERATING ACTIVITIES
Net Income -$139.5K
YoY Change 130.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9013501 usd
CY2024Q4 fil Reserves
Reserves
366493 usd
CY2024Q2 fil Reserves
Reserves
366493 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9016666 usd
dei Document Period End Date
DocumentPeriodEndDate
2024-11-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54500
dei Entity Registrant Name
EntityRegistrantName
Stimcell Energetics Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3939625
dei Entity Address Address Line1
EntityAddressAddressLine1
1130 Pender Street, West
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 820
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6E 4A4
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
238-2692
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19816272 shares
CY2024Q4 us-gaap Cash
Cash
33821 usd
CY2024Q2 us-gaap Cash
Cash
43415 usd
CY2024Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4525 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2707 usd
CY2024Q4 us-gaap Assets
Assets
38346 usd
CY2024Q2 us-gaap Assets
Assets
46122 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
316282 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
288891 usd
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12340 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28058 usd
CY2024Q4 fil Due To Related Party Current
DueToRelatedPartyCurrent
325945 usd
CY2024Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
231138 usd
CY2024Q4 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
366484 usd
CY2024Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
324490 usd
CY2024Q4 us-gaap Liabilities
Liabilities
1021051 usd
CY2024Q2 us-gaap Liabilities
Liabilities
872577 usd
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19816272 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
19816 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
19816 usd
CY2023Q4 us-gaap Management Fee Expense
ManagementFeeExpense
0 usd
us-gaap Management Fee Expense
ManagementFeeExpense
45000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
0 usd
CY2024Q4 fil Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
0 usd
CY2023Q4 fil Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
301 usd
fil Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
0 usd
fil Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
607 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
130698 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
42562 usd
us-gaap Operating Expenses
OperatingExpenses
190334 usd
us-gaap Operating Expenses
OperatingExpenses
93616 usd
CY2024Q4 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2023Q4 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
1569 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2024Q4 us-gaap Interest Expense
InterestExpense
8810 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
17985 usd
us-gaap Interest Expense
InterestExpense
17662 usd
us-gaap Interest Expense
InterestExpense
43884 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
-139508 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-60547 usd
us-gaap Profit Loss
ProfitLoss
-206427 usd
us-gaap Profit Loss
ProfitLoss
-137500 usd
CY2024Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
65533 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6420 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
47012 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2512 usd
CY2024Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73975 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54127 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-159415 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140012 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19816272 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4194871 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19816272 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4194871 shares
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2385480 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-76953 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-8932 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2471365 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-60547 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
6420 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2525492 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826455 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3165 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-66919 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-18521 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-908730 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
-139508 usd
CY2024Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
65533 usd
CY2024Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-982705 usd
us-gaap Profit Loss
ProfitLoss
-206427 usd
us-gaap Profit Loss
ProfitLoss
-137500 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
14239 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
34197 usd
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
3423 usd
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
9687 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
1569 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-36041 usd
us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-629 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1886 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4747 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28361 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17928 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15699 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-28230 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
104081 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
22857 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39436 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75685 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
-158 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
13 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9594 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-75672 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43415 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98295 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33821 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22623 usd
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1-for-15 Reverse Split
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
authorized capital was decreased from 7,500,000,000 shares of common stock with par value of $0.001, of which 297,236,373 shares were outstanding immediately prior to the Reverse Split, to 500,000,000 shares of common stock with par value of $0.001, of which 19,816,272 were outstanding
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7500000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
297236373 shares
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19816272 shares
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10501690 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10501690 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10295263 usd
CY2024Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
116010 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
68998 usd
CY2024Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-982705 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826455 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38346 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46122 usd
CY2024Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
34743 usd
CY2023Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
29470 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
69637 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
59471 usd
CY2024Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-50774 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-4641 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-36565 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
768 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22681 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8150 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39132 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34306 usd
CY2024Q4 us-gaap Management Fee Expense
ManagementFeeExpense
22500 usd
CY2024Q4 fil Due To Related Party Current
DueToRelatedPartyCurrent
325945 usd
CY2024Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
231138 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
114637 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
59471 usd
CY2024Q4 us-gaap Loans Payable
LoansPayable
315759 usd
CY2024Q4 us-gaap Interest Payable Current
InterestPayableCurrent
50725 usd
CY2024Q4 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
366484 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
287466 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
37024 usd
CY2024Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
324490 usd
CY2024Q4 fil Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
10707 usd
CY2024Q2 fil Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
11000 usd
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1-for-15 Reverse Split
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7500000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
297236373 shares
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19816272 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
166669 shares
CY2024Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
166669 shares
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.6
us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.75
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Entity Central Index Key
EntityCentralIndexKey
0001493712
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001393905-25-000019-index-headers.html Edgar Link pending
0001393905-25-000019-index.html Edgar Link pending
0001393905-25-000019.txt Edgar Link pending
0001393905-25-000019-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stme-20241130.htm Edgar Link pending
stme-20241130.xsd Edgar Link pending
stme_ex1073.htm Edgar Link pending
stme_ex311.htm Edgar Link pending
stme-20241130_pre.xml Edgar Link unprocessable
stme-20241130_lab.xml Edgar Link unprocessable
stme-20241130_htm.xml Edgar Link completed
stme_ex312.htm Edgar Link pending
stme_ex321.htm Edgar Link pending
stme_ex322.htm Edgar Link pending
stme-20241130_cal.xml Edgar Link unprocessable
stme-20241130_def.xml Edgar Link unprocessable